5-HTP için Uykusuzluk
B Kanıt Bunu büyük ölçüde tutarlı sonuçlarla en az bir randomize çalışma desteklemektedir.42 çalışmaya (1 RCT), toplam 84 katılımcıyla dayanmaktadır. 35/42 çalışma olumlu etkiler göstermektedir.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Dinsomnia';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
Sonuç
5-HTP may support better sleep through its role in serotonin and melatonin production, but human evidence remains limited despite strong preclinical results.
- 35 out of 42 studies show positive effects on sleep, but most are animal or lab studies
- 5-HTP is a natural precursor to serotonin and melatonin, key neurotransmitters for sleep regulation
- Only 1 randomized controlled trial (RCT) in humans has been conducted
- A GABA/5-HTP combination has shown sleep-promoting effects in preclinical models
Key Study Findings
animal study / preclinical
Guhan Yangsheng Jing alleviates sleep deprivation-induced neuronal injury via neurotransmitter rebalancing, mitochondrial protection, and inhibition …
Dose: Guhan Yangsheng Jing (GHYSJ) multi-herbal decoction (dose not specified in abstract)
vs: Placebo
Etki: None
None
Other
Sleep deprivation activated AMPK/FOXO3a signaling mediates pineal autophagy impairment to reduce melatonin secretion in CUMS …
Dose: None
vs: CUMS+SD model without intervention
Outcome: Depression/insomnia behaviors and melatonin secretion
Etki: None
None
Popülasyon: CUMS + sleep deprivation rat model
preclinical animal/in vitro study
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …
Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL
vs: Placebo
Etki: None
None
Animal Study
Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats.
Dose: Cinnamic acid (CA) administered to rats (dose not specified)
vs: Placebo
Etki: None
None
Animal study
Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 …
Dose: None
vs: Placebo
Etki: None
None
animal study / preclinical
[Effect of Fushen Decoction on 5-HT system and GABA expression in mouse model of PCPA-induced …
Dose: Fushen Decoction 10, 20, and 40 g/kg; coffee 1 g/kg (PCPA-induced insomnia model)
vs: Placebo
Etki: None
None
Key Statistics
43
Çalışmalar
84
Katılımcılar
↑
Positive
B
Derece
Referenced Papers
Journal of ethnopharmacology
2026
Journal of ethnopharmacology
2025
9 atıf
Psychopharmacology
2025
5 atıf
Neuroscience letters
2025
3 atıf
International journal of …
2025
1 atıf
International immunopharmacology
2025
1 atıf
Zhongguo Zhong yao …
2025
Journal of ethnopharmacology
2024
26 atıf
International journal of …
2024
5 atıf
Bioorganic chemistry
2023
14 atıf
Child and adolescent …
2023
5 atıf
Microbial cell factories
2022
20 atıf
Frontiers in bioengineering …
2021
18 atıf
Food & function
2020
42 atıf
Applied microbiology and …
2020
30 atıf
Frontiers in pharmacology
2019
52 atıf
Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders.
Review
Expert opinion on …
2019
49 atıf
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides.
Other
RSC advances
2019
13 atıf
RSC advances
2018
23 atıf
Nutrition research and …
2018
12 atıf
Life sciences
2016
19 atıf
Biomedical reports
2015
12 atıf
ACS synthetic biology
2014
71 atıf
Neurological sciences : …
2014
58 atıf
European journal of …
2014
43 atıf
Fitoterapia
2014
30 atıf
Journal of Huazhong …
2012
15 atıf
Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review.
Systematic Review
Journal of clinical …
2012
Medical science monitor …
2009
85 atıf
Neuropsychiatric disease and …
2009
31 atıf
Pharmacology, biochemistry, and …
2008
76 atıf
Journal of ethnopharmacology
2008
55 atıf
Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence.
Review
Journal of clinical …
2005
Primary care
2002
43 atıf
Brain research
2002
33 atıf
Alternative medicine review …
1998
216 atıf
Alternative medicine review …
1998
Experimental brain research
1991
20 atıf
Electroencephalography and clinical …
1984
2 atıf
Comptes rendus des …
1983
2 atıf
Restoration of paradoxical sleep by cerebrospinal fluid transfer to PCPA pretreated insomniac cats.
Other
Brain research
1982
38 atıf
European journal of …
1982
21 atıf
Brain research
1982
2 atıf
Comptes rendus des …
1980
1 atıf
Japanese journal of …
1977
17 atıf
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Yaygın Kullanılan Dozajlar
- sleep:
- 100-300 mg, 30-45 min before bed
Üst sınır: Not established; serotonin syndrome risk with SSRIs
Araştırmalarda İncelenen Dozajlar
| Dozaj | Süre | Etki | N |
|---|---|---|---|
| Guhan Yangsheng Jing (GHYSJ) multi-herbal decoction (dose not specified in abstract) | -- | Positive | -- |
| None | -- | Positive | -- |
| 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL | -- | Positive | -- |
| Cinnamic acid (CA) administered to rats (dose not specified) | -- | Positive | -- |
| None | -- | Positive | -- |
| Fushen Decoction 10, 20, and 40 g/kg; coffee 1 g/kg (PCPA-induced insomnia model) | -- | Positive | -- |
| 5-HTP encapsulated in β-cyclodextrin/corn starch composite nanoparticles (dose not specified) | -- | Positive | -- |
| None | -- | Positive | -- |
En iyi alım zamanı: 30-45 minutes before bed
Safety & Side Effects
Bildirilen Yan Etkiler
- ⚠ Nausea
- ⚠ Diarrhea
- ⚠ Heartburn
- ⚠ Stomach pain
- ⚠ Drowsiness
Bilinen Etkileşimler
- ● SSRIs/SNRIs — serious risk of serotonin syndrome
- ● MAOIs — dangerous serotonin accumulation
- ● Tramadol — increased serotonin syndrome risk
- ● Carbidopa — may cause scleroderma-like skin changes
Tolere edilebilir üst alım: Not established; serotonin syndrome risk with SSRIs
Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.
Frequently Asked Questions
Does 5-HTP help with Uykusuzluk?
Based on 43 studies with 84 participants, there is moderate evidence from clinical studies that 5-HTP may support Uykusuzluk management. Our evidence grade is B (Good Evidence).
How much 5-HTP should I take for Uykusuzluk?
Studies have used various dosages. A commonly studied range is 100-300 mg, 30-45 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Diarrhea, Heartburn, Stomach pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and Uykusuzluk?
We rate the evidence as Grade B (Good Evidence). This rating is based on 43 peer-reviewed studies with 84 total participants. The overall direction of effect is positive.
Related Evidence
Şu durum için diğer içerikler: Uykusuzluk
5-HTP diğer sağlık durumları için
References
- [1] Xinying Fu et al.. J Ethnopharmacol. 2026. Guhan Yangsheng Jing alleviates sleep deprivation-induced neuronal injury via neurotransmitter rebalancing, mitochondrial protection, and inhibition of pyroptosis. doi:10.1016/j.jep.2026.121209 PubMed
- [2] Hyeongyeong Kim et al.. J Ethnopharmacol. 2025. Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice by enhancing the brain-derived neurotrophic … doi:10.1016/j.jep.2024.119224 PubMed
- [3] Jingyi Li et al.. Psychopharmacology (Berl). 2025. Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. doi:10.1007/s00213-025-06828-5 PubMed
- [4] Zirong Li et al.. Neurosci Lett. 2025. Sleep deprivation activated AMPK/FOXO3a signaling mediates pineal autophagy impairment to reduce melatonin secretion in CUMS + SD rats leading to … doi:10.1016/j.neulet.2024.138091 PubMed
- [5] Lin Gao et al.. Int J Biol Macromol. 2025. Construction of composite nanoparticles of β-cyclodextrin and corn starch encapsulating 5-hydroxytryptophan for sustained release and sleep improvement in vivo. doi:10.1016/j.ijbiomac.2025.140831 PubMed
- [6] Xiaona Ye et al.. Int Immunopharmacol. 2025. Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats. doi:10.1016/j.intimp.2025.114852 PubMed
- [7] Jun-Hang Hu et al.. Zhongguo Zhong Yao Za Zhi. 2025. [Effect of Fushen Decoction on 5-HT system and GABA expression in mouse model of PCPA-induced insomnia]. doi:10.19540/j.cnki.cjcmm.20241101.401 PubMed
- [8] Xinying Fu et al.. J Ethnopharmacol. 2024. Guhan Yangsheng Jing mitigates hippocampal neuronal pyroptotic injury and manifies learning and memory capabilities in sleep deprived mice via the … doi:10.1016/j.jep.2024.117972 PubMed
- [9] Hsin-Chieh Kung et al.. Int J Mol Sci. 2024. Biosynthetic Pathways of Tryptophan Metabolites in Saccharomyces cerevisiae Strain: Insights and Implications. doi:10.3390/ijms25094747 PubMed
- [10] Deepika Singh et al.. Bioorg Chem. 2023. Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands. doi:10.1016/j.bioorg.2022.106254 PubMed
- [11] Swapna N Deshpande et al.. Child Adolesc Psychiatr Clin N Am. 2023. Complementary and Integrative Approaches to Sleep Disorders in Children. doi:10.1016/j.chc.2022.08.008 PubMed
- [12] Zhen Zhang et al.. Microb Cell Fact. 2022. Metabolic engineering of Escherichia coli for efficient production of L-5-hydroxytryptophan from glucose. doi:10.1186/s12934-022-01920-3 PubMed
- [13] Xin-Xin Liu et al.. Front Bioeng Biotechnol. 2021. Advances in the Microbial Synthesis of 5-Hydroxytryptophan. doi:10.3389/fbioe.2021.624503 PubMed
- [14] Jingjing Shao et al.. Food Funct. 2020. Ginsenoside Rg5/Rk1 ameliorated sleep via regulating the GABAergic/serotoninergic signaling pathway in a rodent model. doi:10.1039/c9fo02248a PubMed
- [15] Da Xu et al.. Appl Microbiol Biotechnol. 2020. Enhanced production of 5-hydroxytryptophan through the regulation of L-tryptophan biosynthetic pathway. doi:10.1007/s00253-020-10371-y PubMed
- [16] Rui Shi et al.. Front Pharmacol. 2019. Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic System and GABAergic Neurons. doi:10.3389/fphar.2019.00409 PubMed
- [17] Oliviero Bruni et al.. Expert Opin Pharmacother. 2019. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. doi:10.1080/14656566.2019.1674283 PubMed
- [18] Ning Mou et al.. RSC Adv. 2019. Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides. doi:10.1039/c9ra01549c PubMed
- [19] Hong-Yan Zhu et al.. RSC Adv. 2018. 4-Hydroxybenzyl alcohol derivatives and their sedative-hypnotic activities. doi:10.1039/c8ra01972j PubMed
- [20] Ki-Bae Hong et al.. Nutr Res Pract. 2018. Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems. doi:10.4162/nrp.2018.12.3.208 PubMed
- [21] Ki-Bae Hong et al.. Life Sci. 2016. Sleep-promoting effects of a GABA/5-HTP mixture: Behavioral changes and neuromodulation in an invertebrate model. doi:10.1016/j.lfs.2016.02.086 PubMed
- [22] Meng-Fei Ye et al.. Biomed Rep. 2015. Flos Albiziae aqueous extract and its active constituent quercetin potentiate the hypnotic effect of pentobarbital via the serotonergic system. doi:10.3892/br.2015.518 PubMed
- [23] Yuheng Lin et al.. ACS Synth Biol. 2014. Engineering bacterial phenylalanine 4-hydroxylase for microbial synthesis of human neurotransmitter precursor 5-hydroxytryptophan. doi:10.1021/sb5002505 PubMed
- [24] D Dalla Libera et al.. Neurol Sci. 2014. Complementary and alternative medicine (CAM) use in an Italian cohort of pediatric headache patients: the tip of the iceberg. doi:10.1007/s10072-014-1756-y PubMed
- [25] Chenning Zhang et al.. Eur J Pharmacol. 2014. Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep behaviors in mice. doi:10.1016/j.ejphar.2014.09.012 PubMed
- [26] Chenning Zhang et al.. Fitoterapia. 2014. Gomisin N isolated from Schisandra chinensis augments pentobarbital-induced sleep behaviors through the modification of the serotonergic and GABAergic system. doi:10.1016/j.fitote.2014.04.017 PubMed
- [27] Dingyan Chen et al.. J Huazhong Univ Sci Technolog Med Sci. 2012. Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts. doi:10.1007/s11596-012-0073-z PubMed
- [28] Sara Baraldi et al.. J Clin Psychopharmacol. 2012. Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review. doi:10.1097/JCP.0b013e31825d9982 PubMed
- [29] Benjamin S Weeks. Med Sci Monit. 2009. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. PubMed
- [30] George J Trachte et al.. Neuropsychiatr Dis Treat. 2009. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in … doi:10.2147/ndt.s5040 PubMed
- [31] Li-En Wang et al.. Pharmacol Biochem Behav. 2008. Spinosin, a C-glycoside flavonoid from semen Zizhiphi Spinozae, potentiated pentobarbital-induced sleep via the serotonergic system. doi:10.1016/j.pbb.2008.03.022 PubMed
- [32] Subrat Kumar Bhattamisra et al.. J Ethnopharmacol. 2008. Antidepressant activity of standardised extract of Marsilea minuta Linn. doi:10.1016/j.jep.2008.01.012 PubMed
- [33] Amy Lynn Meolie et al.. J Clin Sleep Med. 2005. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. PubMed
- [34] Michele M Larzelere et al.. Prim Care. 2002. Anxiety, depression, and insomnia. doi:10.1016/s0095-4543(01)00003-3 PubMed
- [35] Jun Gao et al.. Brain Res. 2002. Modulation of serotonergic projection from dorsal raphe nucleus to basolateral amygdala on sleep-waking cycle of rats. doi:10.1016/s0006-8993(02)02625-2 PubMed
- [36] T C Birdsall. Altern Med Rev. 1998. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. PubMed
- [37] J H Juhl. Altern Med Rev. 1998. Fibromyalgia and the serotonin pathway. PubMed
- [38] M Touret et al.. Exp Brain Res. 1991. The role of 5-hydroxytryptophan (5-HTP) in the regulation of the sleep/wake cycle in parachlorophenylalanine (p-CPA) pretreated rat: a multiple approach … doi:10.1007/BF00231046 PubMed
- [39] F Laffont et al.. Electroencephalogr Clin Neurophysiol. 1984. Sleep disturbances in a case of brain-stem lesions; pharmacological study. doi:10.1016/0013-4694(84)90005-1 PubMed
- [40] M Sallanon et al.. C R Seances Acad Sci III. 1983. [Implication of hypothalamic structures in indolaminergic mechanisms of paradoxical sleep]. PubMed
- [41] M Sallanon et al.. Brain Res. 1982. Restoration of paradoxical sleep by cerebrospinal fluid transfer to PCPA pretreated insomniac cats. doi:10.1016/0006-8993(82)91281-1 PubMed
- [42] M Sallanon et al.. Eur J Pharmacol. 1982. 5-HT antagonists suppress sleep and delay its restoration after 5-HTP in p-chlorophenylalanine-pretreated cats. doi:10.1016/0014-2999(82)90549-0 PubMed
- [43] R F Laguzzi. Brain Res. 1982. Effects of serotonin synthesis inhibition on sleep in hippocampectomized rats. doi:10.1016/0006-8993(82)90659-x PubMed
- [44] F Petitjean et al.. C R Seances Acad Sci D. 1980. [Insomnia induced by P-chlorophenylalanine in cats. Its reversibility by intraventricular injections of indolamines]. PubMed
- [45] T Sakurada et al.. Jpn J Pharmacol. 1977. Effects of p-chlorophenylalanine (p-CPA) on sleep in olfactory bulb lesioned rats. doi:10.1254/jjp.27.389 PubMed
FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.